K403-1285 Screening compound: ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate

K403-1285 Screening compound: ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate
K403-1285 Screening compound: ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound K403-1285
ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K403-1285

Molecular Formula

C28H35N5O5S2 (C28 H35 N5 O5 S2)

Compound Name

ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-1,2,4-triazol-3-yl)sulfanyl]propanamido}-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylate

IUPAC name

ethyl 2-{2-[(4-butyl-5-{[(2-methoxyphenyl)formamido]methyl}-4H-124-triazol-3-yl)sulfanyl]propanamido}-4H5H6H-cyclopenta[b]thiophene-3-carboxylate

SMILES

CCCCn1c(SC(C)C(Nc2c(C(OCC)=O)c(CCC3)c3s2)=O)nnc1CNC(c(cccc1)c1OC)=O

InChI

InChI=1S/C28H35N5O5S2/c1-5-7-15-33-22(16-29-25(35)18-11-8-9-13-20(18)37-4)31-32-28(33)39-17(3)24(34)30-26-23(27(36)38-6-2)19-12-10-14-21(19)40-26/h8-9,11,13,17H,5-7,10,12,14-16H2,1-4H3,(H,29,35)(H,30,34)/t17-/m0/s1

InChI Key

XKHUCXGRGXQCAI-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD04411607

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

585.75

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

16.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.882

Distribution Coefficient, logD

2.560

Water Solubility, LogSw

-4.63

Polar Surface Area

101.708

Acid Dissociation Constant (pKa)

5.08

Base Dissociation Constant (pKb)

2.47

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.40

K403-1285 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K403-1285 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K403-1285?
Check Price and Availability of K403-1285, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K403-1285 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K403-1285
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K403-1285
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K403-1285 available by request